Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | PARP1 | P09874 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | PARP10 | Q53GL7 | 6/20 | 0.53 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28312400 | 1.00 | TDP1 (0.62) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| SCHEMBL3020894 | 0.85 | POLB (0.60) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| SCHEMBL10693090 | 0.85 | POLB (0.60) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| Carbamic Acid SCHEMBL30873811 | 0.84 | HDAC1 (0.54) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| SCHEMBL1552114 | 0.82 | HDAC1 (0.64) | TDP1L3MBTL1TSHRHDAC1HDAC8 | |
| SCHEMBL28076408 | 0.82 | RECQL (0.56) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| Terephthalamide SCHEMBL27486747 | 0.81 | PARP1 (0.94) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| Terephthalamide SCHEMBL27828697 | 0.81 | PARP1 (0.82) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| SCHEMBL3714973 | 0.80 | CYP2C19 (0.54) | TDP1L3MBTL1POLBCYP3A4PARP1 | |
| Urea SCHEMBL11343636 | 0.79 | HDAC1 (0.50) | TDP1L3MBTL1POLBCYP3A4PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4615855-A2 | NEW ANTIBACTERIAL PRODUCTS | University of Liverpool (GB) | 2025-09-17 | — | — | EP | disclosed |
| EP-3592761-B1 | NEW ANTIBACTERIAL PRODUCTS | UNIV LIVERPOOL (GB) | 2025-05-14 | — | — | EP | disclosed |
| CN-119731020-A | Multilayer structure, method for producing same, automobile component, aircraft component, and vibration-resistant material for carbon fiber reinforced plastic | 三菱化学株式会社 | 2025-03-28 | — | — | CN | disclosed |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-10-03 | — | — | US | disclosed |
| CN-118652217-A | Star-structure organic interface modification material, preparation method thereof and application thereof in perovskite solar cell | 中节能太阳能科技（镇江）有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2024100391-A2 | NEW ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LIVERPOOL (GB) | 2024-05-16 | — | — | WO | disclosed |
| CN-117836367-A | Resin composition, molded article, modifier for ABS resin, method for producing resin composition, and method for modifying ABS resin | 三菱化学株式会社 | 2024-04-05 | — | — | CN | disclosed |
| US-11897970-B2 | Antibacterial products | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-02-13 | — | — | US | disclosed |
| EP-4005600-A1 | CYTOTOXIC-DRUG DELIVERING MOLECULES TARGETING HIV (CDM-HS), CYTOTOXIC ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USE | Yale University (US) | 2022-06-01 | — | — | EP | disclosed |
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2021-05-13 | — | — | US | disclosed |
| EP-1068216-A2 | LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS | ISIS INNOVATION LIMITED (GB) | 2001-01-17 | — | — | EP | disclosed |
| WO-2000078708-A1 | SUBSTITUTED BENZAMIDE INHIBITORS OF RHINOVIRUS 3C PROTEASE | AGOURON PHARMACEUTICALS, INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| US-6008372-A | ANTICARCINOGENIC, ANTIRESTENOSIS AND ANTIPSORIASIS AGENT | WARNER-LAMBERT COMPANY (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999060007-A2 | LIBRARIES OF OLIGOMERS LABELLED WITH DIFFERENT TAGS | ISIS INNOVATION LIMITED (GB) | 1999-11-25 | — | — | WO | disclosed |
| US-5874589-A | Methods for synthesizing diverse collections of tetramic acids and derivatives thereof | GLAXO WELLCOME, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1997026246-A1 | SUBSTITUTED HISTIDINE INHIBITORS OF PROTEIN FARNESYLTRANSFERASE | WARNER-LAMBERT COMPANY (US) | 1997-07-24 | — | — | WO | disclosed |
| EP-0659188-A4 | METHODS FOR THE SYNTHESIS OF PHOSPHONATE ESTERS. | AFFYMAX TECH NV (AN) | 1995-11-22 | — | — | EP | disclosed |
| EP-0659188-A1 | METHODS FOR THE SYNTHESIS OF PHOSPHONATE ESTERS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1995-06-28 | — | — | EP | disclosed |
| US-5420328-A | Esterification with alcohol and hydrolysis | AFFYMAX TECHNOLOGIES, N.V. (AN) | 1995-05-30 | — | — | US | disclosed |
| WO-1994006808-A1 | METHODS FOR THE SYNTHESIS OF PHOSPHONATE ESTERS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1994-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139539-A1 | NEW ANTIBACTERIAL PRODUCTS | DBI, MRPL21, NRDC | TDP1 4757/4885L3MBTL1 3352/4885POLB 1556/4885 |
| US-11897970-B2 | Antibacterial products | DBI, PDIA5, ABCB11 | TDP1 4630/4885L3MBTL1 2771/4885POLB 1627/4885 |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | DBI, PDIA5, ABCB11 | TDP1 4630/4885L3MBTL1 2771/4885POLB 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.